Effect of Trikantakadya Guggulu in Mutrakrichchra (urinary tract infection)

A Clinical Study on the Management of Mutrakrichchra With Trikantakadya Guggulu

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/02/017710

Enrollment

Registered

2019-02-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Trikantakadya guggulu 1.5 gm thrice daily after food with water for 14 days: Trikantakadya guggula is classical Ayurvedic medicine having reference Yogaratnakara, Mutrakrichcha Adyaya C

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with mutrakrichchra (lower UTI) based on signs symptoms. Positive urine microscopy (pus cells >10/hpf) in centrifuged mid-stream urine.

Exclusion criteria

Exclusion criteria: UTI with secondary systemic disease like renal failure, Uncontrolled systemic disease like Diabetes Mellitus Hypertension & any anatomical abnormalities Evidence of renal calculus.

Design outcomes

Primary

Measure	Time frame
Effect on number of pus cells and RBC per HPF.Timepoint: At base line and at the end of 14 days	—

Secondary

Measure	Time frame
Effect on symptoms of Mutrakrichcha - Burning micturition(Sadaha mutra pravritti) and Dysuria(Saruja mutra pravritti)Timepoint: At base line and after each 7 days till the end of 14 days	—

Countries

India

Contacts

Public ContactDr Payjani Dubey

Parul Institute of Ayurved, Parul university

payald613@gmail.com7748084342

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026